Skip to main content
Clinical Trials/NCT05961137
NCT05961137CompletedNot Applicable

Orange Park Out-of-Hospital Quality Improvement Study for Improving CMS Sepsis Core Measures

Orange Park Medical Center1 site in 1 country66 target enrollmentStarted: April 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
66
Locations
1
Primary Endpoint
Percentage compliance with the CMS 3-hour sepsis bundle criterion (SEP-1) for patients with suspected sepsis

Study Overview

Brief Summary

The goal of this quality improvement study is to measure the impact of incorporation of a manual rapid fluid infuser (RFI) for intravenous crystalloid infusion in patients with suspected sepsis in the prehospital interval.

The main question[s] it aims to answer are:

  • Does the intervention affect the timeliness of fluid administration?
  • Does the intervention affect CMS sepsis bundle care measure compliance?
  • Does the intervention affect processes and outcomes of care?
  • Are there any adverse effects?

Researchers will compare this intervention to use of more conventional gravity or pressure-infusion bag crystalloid infusion.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients meeting sepsis alert criteria who were transported to the study hospital's emergency department by one of the four rescue units involved in the study. Sepsis alert defined as patient has suspected infection and two or more of the following: (a) temperature > 38° C (100.4° F) or < 36° C (96.8° F), (b) respiratory rate > 20 breaths / minute or end-tidal carbon dioxide (ETCO2) ≤ 25 mmHg, or (c) heart rate > 90 beats / minute

Exclusion Criteria

  • •prehospital trauma
  • •prehospital cardiac arrest prior to signaling sepsis alert
  • •interfacility transfer
  • •emergency transport from medical facility (e.g., medical office or clinic)
  • •intervention by medical practitioner before emergency medical services arrival
  • •do not resuscitate order in place

Arms & Interventions

After-phase: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol

Active Comparator

Modified protocol specifying intravenous crystalloid infusion Rapid Fluid Infusion Device. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

Intervention: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol (Other)

Before phase: Conventional Prehospital Suspected Sepsis Protocol

Active Comparator

Conventional protocol employing intravenous crystalloid infusion via gravity or pressurized-bag. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

Intervention: Conventional Prehospital Suspected Sepsis Protocol (Other)

Outcomes

Primary Outcomes

Percentage compliance with the CMS 3-hour sepsis bundle criterion (SEP-1) for patients with suspected sepsis

Time Frame: Assessed at 3 hours after ED arrival

As defined according to the Centers for Medicare and Medicaid Services (CMS) Specifications Manual for Hospital Inpatient Quality Measures, version 5.9. "Time of presentation" or "time-zero" was defined as the time of triage in the Emergency Department. All patients enrolled in the study were assessed for measure compliance, without application of measure inclusion/exclusion criteria.

Secondary Outcomes

  • Total volume of intravenous crystalloid infused by 1 hour after ED arrival(Assessed at 1 hour after ED arrival)
  • Total volume of intravenous crystalloid infused by 3 hours after ED arrival(Assessed at 3 hours after ED arrival)
  • Percentage of study participants receiving any intensive care unit care(Through discharge from index acute-care episode, up to 6 months)
  • Percentage of enrollees experiencing in-hospital death(Through discharge from index acute-care episode, up to 6 months)
  • Total length of stay in ED(Through discharge from index acute-care episode, up to 6 months)
  • Total length of stay in hospital(Through discharge from index acute-care episode, up to 6 months)
  • Total length of stay in intensive care unit(Through discharge from index acute-care episode, up to 6 months)
  • Total volume of intravenous crystalloid infused by time of ED arrival(During the 3 hours prior to ED arrival, while under care by EMS.)
  • Total volume of intravenous crystalloid infused, in the ED, by 1 hour after ED arrival(Assessed at 1 hour after ED arrival)
  • Total volume of intravenous crystalloid infused, in the ED, by 3 hours after ED arrival(Assessed at 3 hours after ED arrival)
  • Percentage of study participants with admission disposition during index ED visit(Through discharge from index acute-care episode, up to 6 months)
  • Percentage achievement of 30mL/kg crystalloid infusion for hypotension or lactate level > 4 mmol/L at 1 hour(Assessed at 1 hour after ED arrival)
  • Percentage of enrollees receiving any specified life-support interventions in the first 24 hours from ED arrival(Assessed at 24 hours after ED arrival)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials